Quarterly report pursuant to Section 13 or 15(d)

Summary of Stock Options Activity (Details)

v3.23.3
Summary of Stock Options Activity (Details)
9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Number of Shares, Beginning Balance | shares 4,476,737
Weighted Average Exercise Price, Beginning Balance $ 2.64
Weighted Average Grant Date Fair Value, Beginning $ 2.64
Weighted Average Remaining Contractual Term (Years), Beginning 7 months 20 days
Aggregate Intrinsic Value, Beginning Balance | $
Number of Shares, Granted | shares 3,845,000
Weighted Average Exercise Price, Granted $ 1.40
Weighted Average Grant Date Fair Value, Granted $ 1.29
Weighted Average Remaining Contractual Term (Years), Granted 8 years 9 months
Number of Shares, Exercised | shares
Weighted Average Exercise Price, Exercised
Weighted Average Grant Date Fair Value, Exercised
Number of Shares, Forfeited | shares
Weighted Average Exercise Price, Forfeited
Weighted Average Grant Date Fair Value, Forfeited
Number of Shares, Canceled/Expired | shares (4,176,737)
Weighted Average Exercise Price, Canceled/Expired $ 2.59
Weighted Average Grant Date Fair Value, Canceled/Expired $ 2.59
Number of Shares, Ending Balance | shares 4,145,000
Weighted Average Exercise Price, Ending Balance $ 1.54
Weighted Average Grant Date Fair Value, Ending $ 1.42
Weighted Average Remaining Contractual Term (Years), Ending 8 years 5 months 19 days
Aggregate Intrinsic Value, Ending Balance | $
Number of Shares, Exercisable | shares 1,214,999
Weighted Average Exercise Price, Exercisable $ 1.38
Weighted Average Grant Date Fair Value, Exercisable $ 1.27
Weighted Average Remaining Contractual Term (Years), Exercisable 8 years 9 months 25 days
Aggregate Intrinsic Value, Exercisable | $